Australia, Feb. 5 -- Actelion Pharmaceuticals Ltd., owns the trademark (2605256) for 'BEXAPHY' till Aug. 29, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for treatment of cardiovascular and pulmonary diseases.]
Type of Mark: Word
Date of Acceptance: Nov. 28, 2025
Registration Advertised: Feb. 4
For further details contact Actelion Pharmaceuticals Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2605256.
Disclaimer: Curated by HT Syndication.
